Label: FUROSEMIDE injection

  • NDC Code(s): 73542-101-25, 73542-102-25, 73542-103-25
  • Packager: Maiva Pharma Private Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL

Drug Label Information

Updated June 13, 2025

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • WARNINGS

    Furosemide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient's needs. (See DOSAGE AND ADMINISTRATION.)
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 73542-101-01
    Furosemide Injection, USP
    20 mg/2 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only
    2 mL Single-Dose vial

    vial-label-2ml

    NDC 73542-101-25
    Furosemide Injection, USP
    20 mg/2 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only
    25 Single-Dose vial

    carton-label-2ml

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 73542-102-02
    Furosemide Injection, USP
    40 mg/4 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only
    4 mL Single-Dose vial

    vial-label-4ml

    NDC 73542-102-25
    Furosemide Injection, USP
    40 mg/4 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only
    25 Single-Dose via

    carton-label-4ml

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 73542-103-03
    Furosemide Injection, USP
    100 mg/10 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only
    10 mL Single-Dose vial

    vial-label-10ml

    NDC 73542-103-25
    Furosemide Injection, USP
    100 mg/10 mL
    (10 mglmL)
    FOR IV OR IM USE
    Rx only

    25 Single-Dose vial

    carton-label-10ml

  • INGREDIENTS AND APPEARANCE
    FUROSEMIDE 
    furosemide injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:73542-101
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE10 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73542-101-2525 in 1 CARTON06/16/2025
    12 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20342806/16/2025
    FUROSEMIDE 
    furosemide injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:73542-102
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE10 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73542-102-2525 in 1 CARTON06/16/2025
    14 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20342806/16/2025
    FUROSEMIDE 
    furosemide injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:73542-103
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) FUROSEMIDE10 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73542-103-2525 in 1 CARTON06/16/2025
    110 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20342806/16/2025
    Labeler - Maiva Pharma Private Limited (725656438)
    Registrant - Maiva Pharma Private Limited (725656438)
    Establishment
    NameAddressID/FEIBusiness Operations
    Maiva Pharma Private Limited725656438analysis(73542-101, 73542-102, 73542-103) , manufacture(73542-101, 73542-102, 73542-103) , pack(73542-101, 73542-102, 73542-103) , label(73542-101, 73542-102, 73542-103)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!